These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20655603)

  • 1. Peptide drugs to target G protein-coupled receptors.
    Bellmann-Sickert K; Beck-Sickinger AG
    Trends Pharmacol Sci; 2010 Sep; 31(9):434-41. PubMed ID: 20655603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine receptors as targets for new drugs.
    Altman J
    Neuroendocrinology; 2006; 83(5-6):282-8. PubMed ID: 16926529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic peptides: technological advances driving peptides into development.
    Sato AK; Viswanathan M; Kent RB; Wood CR
    Curr Opin Biotechnol; 2006 Dec; 17(6):638-42. PubMed ID: 17049837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in strategies to improve drug delivery to brain tumors.
    Newton HB
    Expert Rev Neurother; 2006 Oct; 6(10):1495-509. PubMed ID: 17078789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.
    Low PS; Henne WA; Doorneweerd DD
    Acc Chem Res; 2008 Jan; 41(1):120-9. PubMed ID: 17655275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and future drugs targeting one class of innate immunity receptors: the Toll-like receptors.
    Romagne F
    Drug Discov Today; 2007 Jan; 12(1-2):80-7. PubMed ID: 17198976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovering and improving novel peptide therapeutics.
    McGregor DP
    Curr Opin Pharmacol; 2008 Oct; 8(5):616-9. PubMed ID: 18602024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical and clinical studies of peptide receptor radionuclide therapy.
    Pool SE; Krenning EP; Koning GA; van Eijck CH; Teunissen JJ; Kam B; Valkema R; Kwekkeboom DJ; de Jong M
    Semin Nucl Med; 2010 May; 40(3):209-18. PubMed ID: 20350630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine H3 and H4 receptors as novel drug targets.
    Tiligada E; Zampeli E; Sander K; Stark H
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1519-31. PubMed ID: 19758107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-specific delivery of a chemotherapeutic to lung cancer cells.
    Zhou X; Chang YC; Oyama T; McGuire MJ; Brown KC
    J Am Chem Soc; 2004 Dec; 126(48):15656-7. PubMed ID: 15571383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors.
    Hoare SR
    Drug Discov Today; 2005 Mar; 10(6):417-27. PubMed ID: 15808821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic therapeutic peptides: science and market.
    Vlieghe P; Lisowski V; Martinez J; Khrestchatisky M
    Drug Discov Today; 2010 Jan; 15(1-2):40-56. PubMed ID: 19879957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biophysical delivery of peptides: applicability for cancer therapy.
    Dass CR; Choong PF
    Peptides; 2006 Dec; 27(12):3479-88. PubMed ID: 16996648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promiscuous drugs as therapeutics for chemokine receptors.
    Horuk R
    Expert Rev Mol Med; 2009 Jan; 11():e1. PubMed ID: 19123963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M; Behr TM
    Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic cancer targeting peptides.
    Aina OH; Sroka TC; Chen ML; Lam KS
    Biopolymers; 2002; 66(3):184-99. PubMed ID: 12385037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin targeted drug and gene delivery.
    Wang Z; Chui WK; Ho PC
    Expert Opin Drug Deliv; 2010 Feb; 7(2):159-71. PubMed ID: 20095940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future directions for peptide therapeutics development.
    Kaspar AA; Reichert JM
    Drug Discov Today; 2013 Sep; 18(17-18):807-17. PubMed ID: 23726889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.